1. Home
  2. GYRE vs FVRR Comparison

GYRE vs FVRR Comparison

Compare GYRE & FVRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GYRE
  • FVRR
  • Stock Information
  • Founded
  • GYRE 2002
  • FVRR 2010
  • Country
  • GYRE United States
  • FVRR Israel
  • Employees
  • GYRE N/A
  • FVRR N/A
  • Industry
  • GYRE Biotechnology: Pharmaceutical Preparations
  • FVRR Business Services
  • Sector
  • GYRE Health Care
  • FVRR Consumer Discretionary
  • Exchange
  • GYRE Nasdaq
  • FVRR Nasdaq
  • Market Cap
  • GYRE 897.1M
  • FVRR 957.0M
  • IPO Year
  • GYRE N/A
  • FVRR 2019
  • Fundamental
  • Price
  • GYRE $9.53
  • FVRR $30.75
  • Analyst Decision
  • GYRE
  • FVRR Buy
  • Analyst Count
  • GYRE 0
  • FVRR 12
  • Target Price
  • GYRE N/A
  • FVRR $34.91
  • AVG Volume (30 Days)
  • GYRE 105.9K
  • FVRR 544.3K
  • Earning Date
  • GYRE 05-09-2025
  • FVRR 05-07-2025
  • Dividend Yield
  • GYRE N/A
  • FVRR N/A
  • EPS Growth
  • GYRE N/A
  • FVRR 127.71
  • EPS
  • GYRE 0.04
  • FVRR 0.49
  • Revenue
  • GYRE $100,643,000.00
  • FVRR $405,141,000.00
  • Revenue This Year
  • GYRE $22.01
  • FVRR $12.11
  • Revenue Next Year
  • GYRE $88.14
  • FVRR $8.62
  • P/E Ratio
  • GYRE $213.36
  • FVRR $60.72
  • Revenue Growth
  • GYRE N/A
  • FVRR 10.41
  • 52 Week Low
  • GYRE $6.11
  • FVRR $20.78
  • 52 Week High
  • GYRE $19.00
  • FVRR $36.11
  • Technical
  • Relative Strength Index (RSI)
  • GYRE 55.67
  • FVRR 71.53
  • Support Level
  • GYRE $8.51
  • FVRR $26.04
  • Resistance Level
  • GYRE $9.98
  • FVRR $27.20
  • Average True Range (ATR)
  • GYRE 0.61
  • FVRR 1.01
  • MACD
  • GYRE 0.10
  • FVRR 0.53
  • Stochastic Oscillator
  • GYRE 73.84
  • FVRR 98.77

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

About FVRR Fiverr International Ltd. no par value

Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.

Share on Social Networks: